Therapeutic potential of resveratrol against emerging respiratory viral infections
Under a Creative Commons license
open access
Keywords
Resveratrol
Emerging respiratory viruses
Anti-viral mechanisms
Abbreviations
ACE-2
angiotensin-converting enzyme-2
AHR
airway hyperresponsiveness
ARDS
acute respiratory distress syndrome
GSH
glutathione
HCoV
human coronavirus
hMPV
human metapneumovirus
HRV
human rhinovirus
ICAM-1
intercellular adhesion molecule-1
ICU
intensive care unit
IFN
interferon
IL
interleukin
IRF
interferon regulatory factor
MAPK
p38 mitogen-activated protein kinase
MERS-Cov
middle-east respiratory syndrome coronavirus
MIC
minimal inhibitory concentration
myD88
myeloid differentiation primary response 88
NF-κB
nuclear factor-κB
NK
natural killer
PKC
protein kinase C
RANTES
regulated on Activation Normal T Cell Expressed and Secreted
RNP
ribonucleoprotein
ROS
reactive oxygen species
RSV
respiratory syncytial virus
SARM
Sterile α and HEAT/Armadillo motif–containing protein
SARS-Cov
severe acute respiratory syndrome coronavirus
TBK1
TANK-binding kinase 1
TLR
toll-like receptor
TNFα
tumor necrosis factor-α
TRIF
TIR-domain-containing adapter inducing interferon-β
Cited by (0)
© 2020 The Author(s). Published by Elsevier Inc.